ITHS Tools
Connect with Us
Need Help? Have a Question?

Addressing Rigor and Reproducibility in Your NIH Grant

a woman in a lab coat contemplating

Addressing Rigor and Reproducibility in Your NIH Grant

April 12, 2022 @ 12:00 pm – 1:30 pm America/Los Angeles Timezone
Online Event
Register below to receive Zoom link.
Aric Lane

Event Video

Watch on Vimeo


Beginning in 2016, NIH has required that the rigor and reproducibility of the proposed project be addressed in grant submissions. This session will describe why the inability to reproduce data in published studies has increased, the implications for science, and ways to improve the rigor and reproducibility of studies. In addition, we will discuss tips for addressing rigor and reproducibility requirements in grant submissions.

Event Materials

4 MBPRESENTATION – Addressing Rigor and Reproducibility in Your NIH Grant


Learning Objectives

At the end of the session, participants will be able to:

  1. Understand why lack of reproducibility in science is a problem.
  2. Describe strategies to minimize irreproducibility and increase rigor.
  3. Describe the factors that lead to a lack of reproducibility.


Attendees may wish to download the “Reproducibility and Replicability in Science” report from The National Academies Press as a reference document (not a required pre-read).

3 MBHANDOUT – Rigor and Reproducibility


Schedule of Activities

  • 12:00-12:10pm – Welcome, Overview, Introductions
  • 12:10-1:25pm – Presentation, Interactivity, Q&A
  • 1:25-1:30pm – Thank You and Feedback Survey

About the Speaker

Dr. Andrea LazarusDr. Andrea Lazarus is a clinical professor and Associate Dean for Research in the WSU College of Pharmacy and also serves as Associate Vice President for Health Sciences at WSU, and as Executive Director of the Steve Gleason Institute for Neuroscience. Andrea was previously administrator of the National Institutes of Health-funded Penn State Clinical and Translational Science Institute, and of the Penn State Cancer Institute. She has a PhD in experimental medicine from McGill University, a master’s degree in cell biology from Cornell University and a bachelor’s degree in human genetics from McGill.